Phenylacetylene

Phenylacetylene

SCHEMBL2832826

C#Cc1ccccc1.CCCCCCNCCCCCC

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 5/20 0.56
▸ ALDH1A1 P00352 2/20 0.46
▸ TSHR P16473 1/20 0.46
▸ CHRM2 P08172 1/20 0.44
▸ NAAA Q02083 1/20 0.44
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ S1PR2 O95136 1/20 0.42
▸ S1PR1 P21453 1/20 0.42
▸ S1PR3 Q99500 1/20 0.42
▸ GRIN1 Q05586 2/20 0.42
▸ GRIN2A Q12879 2/20 0.42
▸ EPHX1 P07099 3/20 0.41
▸ HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenylacetylene SCHEMBL27630895 0.82 LTA4H (0.42) SMN1; SMN2
Benzonitrile SCHEMBL8773388 0.82 SIGMAR1 (0.56) SIGMAR1ALDH1A1TSHRCHRM2NAAA
Benzonitrile SCHEMBL8746686 0.82 SIGMAR1 (0.56) SIGMAR1ALDH1A1TSHRCHRM2NAAA
Biphenyl SCHEMBL5716029 0.79 SIGMAR1 (0.66) SIGMAR1ALDH1A1TSHRCHRM2NAAA
Biphenyl SCHEMBL22832517 0.79 SIGMAR1 (0.66) SIGMAR1ALDH1A1TSHRCHRM2NAAA
Benzene SCHEMBL28999857 0.78 TSHR (0.77) SIGMAR1ALDH1A1TSHRCHRM2NAAA
Benzene SCHEMBL28999842 0.78 TSHR (0.77) SIGMAR1ALDH1A1TSHRCHRM2NAAA
Biphenyl SCHEMBL27827416 0.77 SIGMAR1 (0.63) SIGMAR1ALDH1A1TSHRCHRM2NAAA
Phenylacetylene SCHEMBL28009607 0.76 LTA4H (0.49) ALDH1A1TSHRCHRM2MEN1KMT2A
Phenylacetylene SCHEMBL1983361 0.76 DRD2 (0.40) ALDH1A1TSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7842758-B2 Conjugated materials featuring proquinoidal units THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2010-11-30 — — US disclosed
US-20090221762-A1 NOVEL CONJUGATED MATERIALS FEATURING PROQUINOIDAL UNITS THE TRUSSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2009-09-03 — — US disclosed
WO-2007081991-A9 NOVEL CONJUGATED MATERIALS FEATURING PROQUINOIDAL UNITS UNIV PENNSYLVANIA (US) 2007-09-07 — — WO disclosed
WO-2007081991-A2 NOVEL CONJUGATED MATERIALS FEATURING PROQUINOIDAL UNITS THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2007-07-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221762-A1 NOVEL CONJUGATED MATERIALS FEATURING PROQUINOIDAL UNITS PML, ILK, PARG SIGMAR1 2076/4885ALDH1A1 2833/4885TSHR 4843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback